Madrigal Pharmaceuticals, Inc. (MDGL)
511.84
-4.90
(-0.95%)
USD |
NASDAQ |
Aug 24, 16:00
511.84
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Debt to Equity Ratio : 0.664 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.664 |
| March 31, 2026 | 0.6391 |
| December 31, 2025 | 0.5768 |
| September 30, 2025 | 0.5536 |
| June 30, 2025 | 0.1781 |
| March 31, 2025 | 0.1685 |
| December 31, 2024 | 0.1585 |
| September 30, 2024 | 0.1533 |
| June 30, 2024 | 0.1377 |
| March 31, 2024 | 0.1384 |
| December 31, 2023 | 0.2891 |
| September 30, 2023 | 5.239 |
| June 30, 2023 | 0.9628 |
| March 31, 2023 | 0.5636 |
| December 31, 2022 | 0.2528 |
| September 30, 2022 | 4.669 |
| June 30, 2022 | 0.5953 |
| March 31, 2022 | 0.0048 |
| December 31, 2021 | 0.0041 |
| September 30, 2021 | 0.0038 |
| June 30, 2021 | 0.0037 |
| March 31, 2021 | 0.0027 |
| December 31, 2020 | 0.0033 |
| September 30, 2020 | 0.003 |
| June 30, 2020 | 0.0015 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0016 |
| December 31, 2019 | 0.0016 |
| September 30, 2019 | 0.0017 |
| June 30, 2019 | 0.0018 |
| March 31, 2019 | 0.0019 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0008 |
| March 31, 2016 | 0.0526 |
| December 31, 2015 | -0.9935 |
| September 30, 2015 | 0.1154 |
| June 30, 2015 | 0.1346 |
| March 31, 2015 | 0.2513 |
| December 31, 2014 | 0.2135 |
| September 30, 2014 | 0.1937 |
| June 30, 2014 | 0.2503 |
| March 31, 2014 | 0.5467 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Insmed, Inc. | 0.9865 |
| PTC Therapeutics, Inc. | -4.212 |
| Protagonist Therapeutics, Inc. | 0.011 |
| Exelixis, Inc. | 0.09 |
| Karyopharm Therapeutics, Inc. | -0.7759 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.245B |
| Total Liabilities (Quarterly) | 720.92M |
| Shareholders Equity (Quarterly) | 523.72M |
| Current Ratio | 3.205 |
| Net Debt Paydown Yield | -0.37% |